Other
VAS
VAS is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_2
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (50.0%)
N/A1 (50.0%)
Trials by Status
completed267%
not_yet_recruiting133%
Recent Activity
0 active trials
Showing 3 of 3
completed
Myofascial Pain Syndrome in Patients With Breast Cancer-related Lymphedema
NCT06012786
not_yet_recruitingnot_applicable
Effect of Social Isolation on the Role of Pavlovian Mechanisms for Control Over Alcohol Use
NCT06256952
completedphase_2
Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)
NCT02781584
Clinical Trials (3)
Showing 3 of 3 trials
NCT06012786
Myofascial Pain Syndrome in Patients With Breast Cancer-related Lymphedema
NCT06256952Not Applicable
Effect of Social Isolation on the Role of Pavlovian Mechanisms for Control Over Alcohol Use
NCT02781584Phase 2
Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)
All 3 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 3